519 related articles for article (PubMed ID: 24756514)
1. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
2. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
ten Hove MW; Friedman DI; Patel AD; Irrcher I; Wall M; McDermott MP;
J Neuroophthalmol; 2016 Mar; 36(1):13-9. PubMed ID: 26587993
[TBL] [Abstract][Full Text] [Related]
3. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M;
Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
Cello KE; Keltner JL; Johnson CA; Wall M;
J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
[TBL] [Abstract][Full Text] [Related]
5. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
6. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
7. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Wall M; Kupersmith MJ; Thurtell MJ; Moss HE; Moss EA; Auinger P;
Am J Ophthalmol; 2017 Apr; 176():102-107. PubMed ID: 28104417
[TBL] [Abstract][Full Text] [Related]
8. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.
Wall M; Kupersmith MJ; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; McDermott MP;
JAMA Neurol; 2014 Jun; 71(6):693-701. PubMed ID: 24756302
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.
Wall M; Falardeau J; Fletcher WA; Granadier RJ; Lam BL; Longmuir RA; Patel AD; Bruce BB; He H; McDermott MP;
Neurology; 2015 Sep; 85(9):799-805. PubMed ID: 26245929
[TBL] [Abstract][Full Text] [Related]
10. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
Smith SV; Friedman DI
Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
[TBL] [Abstract][Full Text] [Related]
11. The idiopathic intracranial hypertension treatment trial: design considerations and methods.
Friedman DI; McDermott MP; Kieburtz K; Kupersmith M; Stoutenburg A; Keltner JL; Feldon SE; Schron E; Corbett JJ; Wall M;
J Neuroophthalmol; 2014 Jun; 34(2):107-17. PubMed ID: 24739993
[TBL] [Abstract][Full Text] [Related]
12. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
[TBL] [Abstract][Full Text] [Related]
13. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
[TBL] [Abstract][Full Text] [Related]
14. A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension.
Weil R; Kovacs B; Miller N; McDermott MP; Wall M; Kupersmith M; Pi-Sunyer FX;
Obes Sci Pract; 2016 Jun; 2(2):95-103. PubMed ID: 29071096
[TBL] [Abstract][Full Text] [Related]
15. Update on Idiopathic Intracranial Hypertension.
Wall M
Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.
Mollan SP; Mitchell JL; Ottridge RS; Aguiar M; Yiangou A; Alimajstorovic Z; Cartwright DM; Grech O; Lavery GG; Westgate CSJ; Vijay V; Scotton W; Wakerley BR; Matthews TD; Ansons A; Hickman SJ; Benzimra J; Rick C; Singhal R; Tahrani AA; Brock K; Frew E; Sinclair AJ
JAMA Neurol; 2021 Jun; 78(6):678-686. PubMed ID: 33900360
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic intracranial hypertension.
Sinclair AJ; Woolley R; Mollan SP
JAMA; 2014 Sep; 312(10):1059-60. PubMed ID: 25203090
[No Abstract] [Full Text] [Related]
18. A randomised controlled trial of treatment for idiopathic intracranial hypertension.
Ball AK; Howman A; Wheatley K; Burdon MA; Matthews T; Jacks AS; Lawden M; Sivaguru A; Furmston A; Howell S; Sharrack B; Davies MB; Sinclair AJ; Clarke CE
J Neurol; 2011 May; 258(5):874-81. PubMed ID: 21161260
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic intracranial hypertension--reply.
Wall M; McDermott M; Kupersmith M
JAMA; 2014 Sep; 312(10):1060. PubMed ID: 25203092
[No Abstract] [Full Text] [Related]
20. Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial.
Friedman DI; Quiros PA; Subramanian PS; Mejico LJ; Gao S; McDermott M; Wall M;
Headache; 2017 Sep; 57(8):1195-1205. PubMed ID: 28752894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]